Skip to main content

Clinical Drug Investigation

Ausgabe 8/2023

Inhalt (8 Artikel)

Open Access Systematic Review

Healthcare Professional (HCP) and Patient Usability Evaluation and Preferences of Two Auto-injector Devices for Self-Injection of Biosimilars, SB4 and SB5: A Literature Review

Héctor Corominas, David Young, J. R. Fraser Cummings, Yoram Bouhnik, Alessandro Armuzzi, Diamant Thaci, Jihyun Kim

Review Article

Avacopan, a Novel Competitive C5a Receptor Antagonist, for Severe Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis

Ivan D. Nguyen, Evan S. Sinnathamby, Joseph Mason, Bretton Urban, Elisa E. Neuchat, Danielle M. Wenger, Shahab Ahmadzadeh, Sahar Shekoohi, Alan D. Kaye

Original Research Article

Evaluating the Association of Montelukast Use on Neuropsychiatry-Related Healthcare Utilization and Depression in COVID-19-Hospitalized Veterans: A Nationwide VA Observational Cohort Study

Tanvi Patil, Jasper Jade Raguindin, Michelle Radtke, Joseph Smigiel, Natalie Savona, Bush Kavuru, Anuradha Sekhri

Open Access Original Research Article

Cancer Drugs Reimbursed with Limited Evidence on Overall Survival and Quality of Life: Do Follow-Up Studies Confirm Patient Benefits?

Gabriella Chauca Strand, Naimi Johansson, Niklas Jakobsson, Carl Bonander, Mikael Svensson

Original Research Article

Does Opioid Use Disorder Matter for Health Care Utilization Among Lung Cancer Patients? Evidence from U.S. Hospitals During 2016–2020

Jeong-Hui Park, Sun Jung Kim, Lily Grajeda, Alexiya Ramirez, Jongwha Chang

Open Access Original Research Article

Absorption, Metabolism, and Excretion of [14C]-Tolebrutinib After Oral Administration in Humans, Contribution of the Metabolites to Pharmacological Activity

Olivier Nicolas, Patricia Moliner, Patrick Soubayrol, Olivier Vitse, Sebastien Roy, Marie-José Cabanis, Tim Turner, Sylvie Klieber, Stephane Muccio, Catherine Arabeyre, Priscilla Brun